Alagille syndrome (ALGS) is an autosomal-dominant multisystem disorder caused by mutations in Jagged 1 (JAG1) or NOTCH2. The penetrance is low but highly variable.
INTRODUCTION
Alagille syndrome (ALGS) is an autosomal-dominant disorder caused by mutations in Jagged 1 (JAG1) or NOTCH2 (1) . The penetrance is low but highly variable (2) . It is characterized by variable combinations of hepatic anomalies, characteristic facial features and ocular, skeletal, cardiovascular and renal abnormalities (1) . The diagnosis of ALGS is determined by the identification of JAG1 or NOTCH2 mutations.
It is one of the most common causes of intrahepatic cholestasis in infancy (3) and is almost exclusively diagnosed in children (4) . An ALGS diagnosis in adulthood is rare (4, 5) . Here, we report a case of ALGS associated with a novel JAG1 mutation that was diagnosed in adulthood without a well-defined familial history.
CASE REPORT

Clinical manifestations
A 28-year-old male with a nine-year history of abnormal liver biochemistry tests presented to our hospital without any symptoms. His medical history was remarkable due to transient neonatal icterus, atrial septal defect with spontaneous closure at seven years of age and bilateral inborn reduction of vision. He denied a history of excessive alcohol consumption and had never taken any recreational drugs or dietary supplements. His family history was not remarkable.
Physical examination showed a peculiar triangular face with a prominent forehead and a pointed chin, and a harsh blowing systolic murmur was heard at the area of the left internal carotid artery. Laboratory investigations were as follows: alanine aminotransferase 291 U/l (normal 9-50); aspartate aminotransferase 145 U/l (normal Magnetic resonance imaging (MRI) of the liver (Fig. 1A-D) identified multiple nodules in the right lobe that were hyperintense on T1-weighted images and enhanced in the arterial phase. This was followed by a rapid washout and they became almost completely isointense to the liver on the venous and delayed phase, which is typical of benign regenerative nodules. Furthermore, there was no evidence of dilation of the intra-and extra-hepatic bile ducts. Computed tomography (CT) angiograms of the head and neck (Fig. 1E ) revealed a narrowing of the left internal carotid artery.
Liver histology showed the absence of bile ducts in the portal area, while the hepatic arterioles and portal venules were normal (Fig. 1F) . Immunohistochemistry of cytokeratin 7 (CK7) (Fig. 1G ) revealed biliary metaplasia of periportal hepatocytes, indicating chronic cholestasis.
Detection of genetic mutations
ALGS was suspected based on the clinical features of the patient. Informed consent was obtained before a blood sample was taken from the patient and his parents for the analysis of ALGS-associated genes. Mutation analysis of ALGS-associated genes was performed by target sequence capture and next generation sequencing. A novel frameshift mutation, c.2087_2088insAAAAATGG (p. W697Kfs*49), in JAG1 was identified in the patient. This led to a truncated mutant protein of 745 amino acids (Fig. 2 ). This mutation was not identified in either of his parents.
Follow-up
The patient was treated with oral ursodeoxycholic acid but the liver enzyme profile did not change significantly after one year. The patient should have been followedup with blood tests for liver function and alfa-fetoprotein and imaging studies of the liver and cerebral vascular vessels. However, we were unable to contact him for follow-up, even though every effort was made. Treatment of ALGS usually focuses on the consequences of liver disease and the surgical and medical treatment of congenital heart defects. The prognosis of ALGS depends on the severity of the disease in the worst affected organ system. Although hepatocellular carcinoma (HCC) is a rare complication of ALGS, it can develop in ALGS at any age from childhood to the fifth decade of life, with most adult cases occurring at 30-40 years of age (6) . Adult patients may develop HCC without cirrhosis and ALGS itself may be a risk factor for the development of HCC (6).
DISCUSSION
There are no recommendations for the surveillance of HCC in ALGS. However, annual screening for HCC in ALGS patients by serum alpha-fetoprotein and ultrasonography is encouraged due to the fact that the development of HCC is unpredictable and the treatment of HCC at an early stage has a relatively good prognosis (6). The patient described here had several liver nodules. However, unfortunately, we did not have the opportunity to repeat a radiological exam of the liver and further study the nodules histologically. According to the risk of HCC, the patients should be closely monitored by serum alpha-fetoprotein and ultrasonography every six months.
ALGS is one of the most common causes of pediatric chronic liver disease and occurs in one of 70,000 to 100,000 newborns with no sex differentiation (3). However, ALGS diagnosed in adulthood is rare. Several cases of ALGS involving liver disease diagnosed in adulthood have been reported. We searched for cases reported in the literature in English before June 2018, using the terms "Alagille syndrome" OR "arteriohepatic dysplasia" AND "adult". The search retrieved 171 abstracts from PubMed. Among these, there were six reports of ALGS with hepatic involvement diagnosed in adulthood (Table 1) . ALGS is probably underdiagnosed in adult patients as the penetrance of the disorder is low and highly variable. Some adult cases without overt liver disease are almost certainly overlooked and this pediatric disease is largely unknown to adult physicians. indicating that it is a pathogenic variant. However, the mutation was not identified in either of his parents. In fact, approximately 60% of mutations in JAG1 are de novo and germline mosaicism may occur at a frequency up to 8% (1). We speculate that this case may be the result of a spontaneous mutation or that germline mosaicism may occur in his family. Thus, the mutation was not identified in the genomic DNA extracted from blood samples of his parents.
To our knowledge, this is the first report of ALGS diagnosed in adulthood in China.
Due to the fact that the phenotype of ALGS shows a variable expression that ranges from mild cholestasis and cirrhosis to acute liver failure, it should be considered as a differential diagnosis for cholestasis in certain cases with a wide variety of clinical manifestations. These include cardiac disease, skeletal abnormalities, ocular abnormalities and characteristic facial features. The detection of a mutation in JAG1 or NOTCH2 is very helpful to establish the diagnosis of ALGS (1).
In conclusion, we report the first case of ALGS diagnosed in adulthood in China and a novel frameshift mutation c.2087_2088insAAAAATGG was also identified in this patient. 
